BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 1753671)

  • 21. Conjunctival melanocytic lesions. Natural history.
    Henkind P; Benjamin JV
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):373-7. PubMed ID: 273993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical studies of atypical conjunctival melanocytic nevi.
    Jakobiec FA; Colby K; Bajart AM; Saragas SJ; Moulin A
    Arch Ophthalmol; 2009 Aug; 127(8):970-80. PubMed ID: 19667333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound nevus with congenital features and balloon cell changes--an immunohistochemical study.
    Cagnano E; Benharroch D; Sion-Vardy N
    Ann Diagn Pathol; 2008 Oct; 12(5):362-4. PubMed ID: 18774500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens: production, partial characterization and immunohistochemical analysis].
    Fukaya T
    Hokkaido Igaku Zasshi; 1991 May; 66(3):300-10. PubMed ID: 1885156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitheloid cell malignant melanoma of the conjunctiva.
    Karim MM; Inoue M; Ohbayashi C; Ito H
    Kobe J Med Sci; 1995 Oct; 41(5):167-73. PubMed ID: 8929637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monoclonal antibodies in pigmented lesions].
    Puig L; Moreno A; Moragas JM
    Med Cutan Ibero Lat Am; 1987; 15(6):481-8. PubMed ID: 3323707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphometry of melanocytic skin lesions--verifications or vexations? A review of a group experience.
    Williams RA
    Pathologica; 1998 Apr; 90(2):183-5. PubMed ID: 9619064
    [No Abstract]   [Full Text] [Related]  

  • 34. Compound melanocytic nevi with granular cell changes.
    El-Gamal HM; Robinson-Bostom L; Saddler KD; Pan T; Mihm MC
    J Am Acad Dermatol; 2004 May; 50(5):765-6. PubMed ID: 15097962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
    Gown AM; Vogel AM; Hoak D; Gough F; McNutt MA
    Am J Pathol; 1986 May; 123(2):195-203. PubMed ID: 3518473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
    Jiang K; Brownstein S; Lam K; Burns B; Farmer J
    JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Triggered trap": nevoid malignant melanoma.
    McNutt NS
    Semin Diagn Pathol; 1998 Aug; 15(3):203-9. PubMed ID: 9711670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.